Countable Labs and Promega announce co-marketing agreement to facilitate end-to end biological sample preparation and rare variant detection.
Countable PCR delivers single-molecule precision for Europe's most demanding quantification challenges — from cell and gene therapy manufacturing to biomarker validation, diagnostics, commercial ...
Leading life sciences investors ARCH Venture Partners, F-Prime Capital, and Primer Ventures fuel company's expansion into cell and gene therapy, oncology, and molecular diagnostics Countable Labs, the ...
Beth Skwarecki is Lifehacker’s Senior Health Editor, and holds certifications as a personal trainer and weightlifting coach. She has been writing about health for over 10 years. February 21, 2017 Add ...
Matt Elliott is a senior editor at CNET with a focus on laptops and streaming services. Matt has more than 20 years of experience testing and reviewing laptops. He has worked for CNET in New York and ...
TORONTO--(BUSINESS WIRE)--Introducing the new release of Countable, an online platform for small to mid-sized accounting firms to help streamline their practice. Countable combines engagement ...
Countable Labs inks agreement with Promega to facilitate biological sample preparation and rare variant detection: Palo Alto, California Monday, June 29, 2026, 16:00 Hrs [IST] Cou ...
PALO ALTO, Calif., May 28, 2026--(BUSINESS WIRE)--Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, today announced ...